| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/2013 | US8350034 Substituted chiral fused [1,2]imidazo[4,5-C] ring compounds |
| 01/08/2013 | US8350024 Sugar derivatives and application of same |
| 01/08/2013 | US8350016 Oligonucleotide compositions and their use to induce apoptosis |
| 01/08/2013 | US8349987 Adhesive formulations |
| 01/08/2013 | US8349902 Pharmaceutical compositions useful for preventing and treating oncological diseases |
| 01/08/2013 | US8349901 Prodrugs containing novel bio-cleavable linkers |
| 01/08/2013 | US8349900 Bupropion hydrobromide polymorphs |
| 01/08/2013 | US8349899 Selective inhibitors of EG5 motors and methods of use |
| 01/08/2013 | US8349898 Sigma-1 receptor ligands and methods of use |
| 01/08/2013 | US8349897 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 01/08/2013 | US8349896 Aspirin-triggered lipid mediators |
| 01/08/2013 | US8349895 Products containing highly unsaturated fatty acids for use by women during stages of preconception, pregnancy and lactation/post-partum |
| 01/08/2013 | US8349894 Injections of lipophilic amphotericin B |
| 01/08/2013 | US8349893 4-trimethylammonio-butyrates as CPT2 inhibitors |
| 01/08/2013 | US8349892 Solid formulations of prostacyclin analogs |
| 01/08/2013 | US8349891 Crystalline solids of a MetAP-2 inhibitor and methods of making and using same |
| 01/08/2013 | US8349890 Isolongifolanyl-derivatives suitable as odorants |
| 01/08/2013 | US8349889 Skin-care preparations containing mupirocin and betamethasone dipropionate |
| 01/08/2013 | US8349888 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
| 01/08/2013 | US8349886 Nitrogenated 5-membered heterocyclic compound |
| 01/08/2013 | US8349885 Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect |
| 01/08/2013 | US8349884 Fungicide N-cycloalkyl-N-bicyclimethylene-carboxamide derivatives |
| 01/08/2013 | US8349883 Hydroxamate-based inhibitors of deacetylases B |
| 01/08/2013 | US8349882 Pharmaceutical composition for external use |
| 01/08/2013 | US8349880 Bicyclic compounds for the reduction of beta-amyloid production |
| 01/08/2013 | US8349879 Tricyclic compound and pharmaceutical use thereof |
| 01/08/2013 | US8349878 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 01/08/2013 | US8349876 Pyridine non-classical cannabinoid compounds and related methods of use |
| 01/08/2013 | US8349875 Dual-acting antihypertensive agents |
| 01/08/2013 | US8349874 Cyclohexane derivative and pharmaceutical use thereof |
| 01/08/2013 | US8349873 Factor XA inhibitors |
| 01/08/2013 | US8349872 Tripyridyl carboxamide orexin receptor antagonists |
| 01/08/2013 | US8349871 Therapeutic uses of compounds which selectively modulate the CB2 receptor |
| 01/08/2013 | US8349870 Fungicidal hetercyclic compounds |
| 01/08/2013 | US8349869 Macrocylic inhibitors of hepatitis C virus |
| 01/08/2013 | US8349868 Azaquinolones that inhibit prolyl hydroxylase |
| 01/08/2013 | US8349867 Quinoline compounds, intermediates, preparation methods and uses thereof |
| 01/08/2013 | US8349866 High penetration prodrug compositions of 1H-imidazo[4,5-C]quinolin-4-amines and 1H-imidazo[4,5-C]quinolin-4-amine-related compounds |
| 01/08/2013 | US8349865 Inhibitors of janus kinases |
| 01/08/2013 | US8349864 Pyrano [3,2-C] pyridones and related heterocyclic compounds as pharmaceutical agents for treating disorders responsive to apoptosis, antiproliferation or vascular disruption, and the use thereof |
| 01/08/2013 | US8349863 Crystalline polymorphic form of a camptothecin analogue |
| 01/08/2013 | US8349862 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 01/08/2013 | US8349861 Methods for identification of JAK kinase interacting molecules and for the purification of JAK kinases |
| 01/08/2013 | US8349860 Inhibitors of syk and JAK protein kinases |
| 01/08/2013 | US8349859 Pyrimidine derivatives |
| 01/08/2013 | US8349858 Polycyclic guanine derivatives and use thereof |
| 01/08/2013 | US8349857 Quinazoline derivatives having tyrosine kinase inhibitory activity |
| 01/08/2013 | US8349856 Quinazoline based EGFR inhibitors |
| 01/08/2013 | US8349855 Polymorphs of erlotinib hydrochloride and method of preparation |
| 01/08/2013 | US8349854 Salts of 4-aniline quinazoline derivative |
| 01/08/2013 | US8349853 Detection defect in gene expression of hedgehog gene; diagnosis of cancer |
| 01/08/2013 | US8349852 Quinazolinone derivatives useful as vanilloid antagonists |
| 01/08/2013 | US8349851 JAK kinase modulating compounds and methods of use thereof |
| 01/08/2013 | US8349850 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 01/08/2013 | US8349849 Heterobicyclic sphingosine 1-phosphate analogs |
| 01/08/2013 | US8349848 Pyrrolo[3,2-D]pyrimidines that are selective antagonists of A2B adenosine receptors |
| 01/08/2013 | US8349847 Pyrazolo [3,4-D] pyrimidine derivatives as anti-cancer agents |
| 01/08/2013 | US8349846 Fused pyrimidine derivatives as TRPV3 modulators |
| 01/08/2013 | US8349845 Thiazolopyrimidines for use in therapy |
| 01/08/2013 | US8349844 Substituted pyrazolo [1,5-A] pyrimidines as metabotropic glutamate antagonists |
| 01/08/2013 | US8349843 Carboxylic acid derivatives, their preparation and use |
| 01/08/2013 | US8349842 Therapeutic agents useful for treating pain |
| 01/08/2013 | US8349841 Vinyl-aryl derivatives for inflammation and immune-related uses |
| 01/08/2013 | US8349840 Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 01/08/2013 | US8349839 Inhibitors of HIV replication |
| 01/08/2013 | US8349838 Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors |
| 01/08/2013 | US8349837 Pharmaceutical composition comprising racemic aminopterin |
| 01/08/2013 | US8349836 Phthalazine derivatives as inhibitors of protein kinase |
| 01/08/2013 | US8349835 Aromatic ring fused triazine derivatives and uses thereof |
| 01/08/2013 | US8349834 Dioxolane derivates for the treatment of cancer |
| 01/08/2013 | US8349833 Compounds, compositions and methods useful for cholesterol mobilisation |
| 01/08/2013 | US8349832 Compounds and compositions for treating cancer |
| 01/08/2013 | US8349831 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 01/08/2013 | US8349830 Aryl aminopyridine PDE10 inhibitors |
| 01/08/2013 | US8349829 [4-(1-amino-ethyl)-cyclohexyl]-methyl-amine and [6-(1-amino-ethyl)-tetrahydro-pyran-3-yl]-methyl-amine derivatives as antibacterials |
| 01/08/2013 | US8349828 Azatricyclic antibiotic compounds |
| 01/08/2013 | US8349827 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds |
| 01/08/2013 | US8349826 Oxazolidinone derivatives |
| 01/08/2013 | US8349825 Spirocyclic compounds |
| 01/08/2013 | US8349824 Triazolopyridine compounds |
| 01/08/2013 | US8349823 Treatment of renal cell carcinoma |
| 01/08/2013 | US8349822 Treatment of cancer with bio and chemotherapy |
| 01/08/2013 | US8349821 Stanol composition and the use thereof |
| 01/08/2013 | US8349820 Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido |
| 01/08/2013 | US8349819 Steroid extraction process from urine sources |
| 01/08/2013 | US8349818 Method of preventing Type 1 diabetes |
| 01/08/2013 | US8349817 Analogues of cilostazol |
| 01/08/2013 | US8349816 Antibacterial treatment of osteoarthritis |
| 01/08/2013 | US8349815 Synergistic pesticidal mixtures |
| 01/08/2013 | US8349813 Destruction of microbial products by enzymatic digestion |
| 01/08/2013 | US8349812 Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties |
| 01/08/2013 | US8349811 Stable 6-methoxy-2′,3′-dideoxyguanosine, method for preparing the same and pharmaceutical composition containing the same |
| 01/08/2013 | US8349808 Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity |
| 01/08/2013 | US8349806 Method of treating blepharitis |
| 01/08/2013 | US8349792 Combination comprising CNDAC (2′-cyano-2′-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine) and a cytotoxic agent |
| 01/08/2013 | US8349770 Method for the preparation of a composition based on 4-hydroxyproline and the uses thereof in the agronomical field |
| 01/08/2013 | US8349377 Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency |
| 01/08/2013 | US8349376 Anti-dementia regimen |
| 01/08/2013 | US8349368 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms |
| 01/08/2013 | US8349363 Temperature responsive delivery systems |